New prescription medication gaps: a comprehensive measure of adherence to new prescriptions.
about
The role of comfort and discomfort in insulin therapyIdentifying patients with cost-related medication non-adherence: a big-data approachBarriers to insulin initiation: the translating research into action for diabetes insulin starts project.Importance of including early nonadherence in estimations of medication adherence.Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation.Associations between antidepressant adherence and shared decision-making, patient-provider trust, and communication among adults with diabetes: diabetes study of Northern California (DISTANCE).Non-adherence to drug therapy and drug acquisition costs in a national population--a patient-based register study.How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.Social support and lifestyle vs. medical diabetes self-management in the diabetes study of Northern California (DISTANCE)Oral bisphosphonate compliance and persistence: a matter of choice?Incident user cohorts for assessing medication cost-offsetsSafety and effectiveness of mail order pharmacy use in diabetes.Impact of the New ACC/AHA Guidelines on the Treatment of High Blood Cholesterol in a Managed Care Setting.Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures.Patient-reported racial/ethnic healthcare provider discrimination and medication intensification in the Diabetes Study of Northern California (DISTANCE).Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional studyCharacteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disordersFeasibility and impact of implementing a private care system's diabetes quality improvement intervention in the safety net: a cluster-randomized trial.Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIVEthnic Differences in Geriatric Conditions and Diabetes Complications Among Older, Insured Adults With Diabetes: The Diabetes and Aging Study.Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic AttackReach and Validity of an Objective Medication Adherence Measure Among Safety Net Health Plan Members with Diabetes: A Cross-Sectional Study.Improving Patient's Primary Medication Adherence: The Value of Pharmaceutical CounselingMedicare Star excludes diabetes patients with poor CVD risk factor control.Cost-effectiveness of an electronic medical record based clinical decision support system.Food insecurity, processes of care, and self-reported medication underuse in patients with type 2 diabetes: results from the California Health Interview Survey.Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with DiabetesImpact of the Chronic Care Model on medication adherence when patients perceive cost as a barrier.Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes.Non-adherence in type 2 diabetes: practical considerations for interpreting the literatureFinancial Strain and Medication Adherence among Diabetes Patients in an Integrated Health Care Delivery System: The Diabetes Study of Northern California (DISTANCE)Communication and medication refill adherence: the Diabetes Study of Northern California.Primary adherence to antidepressant prescriptions in primary health care: a population-based study in Sweden.Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databasesHealth literacy and antidepressant medication adherence among adults with diabetes: the diabetes study of Northern California (DISTANCE).Refilling medications through an online patient portal: consistent improvements in adherence across racial/ethnic groupsAdherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in JapanAn algorithm to identify medication nonpersistence using electronic pharmacy databases.Impact on glycated haemoglobin of a biological response-based measure of medication adherence.Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users.
P2860
Q27015671-B1AE6E43-DAE1-40E6-A45B-8FCD8F87FCD8Q31070358-F258F243-9C50-4806-9A6C-B1424ACBF4C8Q33751437-CE4CC9A0-D21D-426C-A21C-5C031F70F724Q33852705-33C3E78C-4D56-4A48-8AB6-413159F2E5C7Q33859865-6C1C1BC3-17FB-4D3F-9D62-0771C7D156F2Q33906185-2B1E9F3D-A527-4FE9-B95B-2C85BF0F44C3Q34084953-CEB9BDAB-D8B2-473C-89E4-CA0877476075Q34344393-C05B3FF3-6BA5-4512-8902-2E8BC774B0BAQ34446196-4C8F2EFB-A58B-428C-B970-32BD5D487742Q34472700-7C467988-CBB4-436D-BDA4-56BE7EBBD0C5Q34553899-9A5EE2F4-9115-4E16-BE1D-355E8E08F347Q34782693-C5883983-E06C-4D44-801A-4722EEE3902AQ34792459-DF3B1702-B8D1-4F2D-8CFF-9447F9717539Q34883881-76384814-FE3E-4CDA-9193-72ECEC695346Q35235522-62A6F5BF-F67E-4040-A0E8-63BBBB74AA6FQ35519010-AED20D8F-ABF7-4FAA-8E6F-2745D0F04C52Q35649045-FC7CDDE9-E18D-40FE-953E-22A586F32C42Q35709518-43DDD0DE-BB88-48A3-8D27-F749470DD790Q35836811-8CA2C3E4-12E7-4738-93D5-ED34B3FA71FAQ35842077-B65C880A-03EF-41A5-BA41-BDCDBC7C5C92Q35883245-0ECDC9F9-8937-48E4-A76D-D64CCC60DBAEQ36006414-01D3B59A-9F2A-4AFA-8D29-1F7EB6D74D0DQ36195544-A6E636EB-DB6A-446B-BD6D-04915B6A8887Q36270909-7A11C916-0A96-413D-8504-5A0FFF2DAECEQ36282573-43ADC1B1-E136-4DA7-AEEA-BE07A25C5DBEQ36469841-6B502CDC-9E55-4A98-BBA0-C63AA4662F3BQ36484334-00B43C49-6D8E-41D8-AE58-BE5508DA992EQ36571775-9A1B8996-557B-4353-86F9-B2DB8A5C5041Q36574264-7D664C47-E807-4A09-B459-26EA87000665Q36669031-048DA09F-FBE8-42A8-AF84-31B900E67651Q36706702-2F78A015-2F90-41BE-B76A-C36F6F53FD8CQ36720104-072F34EF-7DD2-488B-A940-792CCA18E9FFQ37013552-8522063F-DACF-44E5-920B-1E2B3B4D6C58Q37055744-16E8EB75-CDD2-4D7F-9D63-506E310071ADQ37097240-C9320444-3939-4AE5-8CA8-3BED33375E09Q37112121-2AE8FBFC-32CF-4224-A057-88C085A69BD4Q37227402-A4A1627F-D998-4C62-BF7C-A7FAC901AE35Q37229253-6CD78832-4A68-47F6-AF31-4DE49820D138Q37275626-54F6C692-0DF5-47A1-84D9-76C6248EC80CQ37409366-DFEF36E8-9DC1-47B4-AEBC-2FB48876843E
P2860
New prescription medication gaps: a comprehensive measure of adherence to new prescriptions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New prescription medication ga ...... dherence to new prescriptions.
@en
New prescription medication ga ...... dherence to new prescriptions.
@nl
type
label
New prescription medication ga ...... dherence to new prescriptions.
@en
New prescription medication ga ...... dherence to new prescriptions.
@nl
prefLabel
New prescription medication ga ...... dherence to new prescriptions.
@en
New prescription medication ga ...... dherence to new prescriptions.
@nl
P2093
P2860
P1476
New prescription medication ga ...... dherence to new prescriptions.
@en
P2093
Ameena T Ahmed
Andrew J Karter
Joe V Selby
Julie A Schmittdiel
Melissa M Parker
P2860
P304
P356
10.1111/J.1475-6773.2009.00989.X
P433
P577
2009-06-03T00:00:00Z